- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Pyrotinib plus trastuzumab and docetaxel and carboplatin
Total 9189 results
-
Fudan UniversityRecruitingLung Cancer, Non-small CellChina
-
European Organisation for Research and Treatment...GlaxoSmithKlineCompletedBreast CancerFrance, United Kingdom, Belgium, Switzerland, Slovenia
-
Zhongshan People's Hospital, Guangdong, ChinaRecruiting
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdUnknown
-
Finnish Breast Cancer GroupCompleted
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche; CephalonCompleted
-
Chinese PLA General HospitalUnknownNeoplasms, Therapy-AssociatedChina
-
Vector OncologyEisai Inc.TerminatedHER-2 Positive Breast CancerUnited States
-
Shanghai Jiao Tong University School of MedicineShanghai 10th People's Hospital; Jiangxi Provincial Cancer Hospital; Shanghai... and other collaboratorsRecruitingRecurrent Non-small Cell Lung CancerChina
-
Sun Yat-sen UniversityRecruitingBreast Cancer | Breast Diseases | HER2-positive Breast Cancer | Vinorelbine | PyrotinibChina
-
Zhenzhen LiuRecruitingBreast Cancer | Triple Negative Breast Cancer | CamrelizumabChina
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingNon-squamous NSCLC | HER2 Exon 20 MutationKorea, Republic of, United States, Taiwan, Belgium, Spain, China, Australia, Turkey, Italy, France, Germany, Poland, Russian Federation
-
Henan Cancer HospitalWithdrawnBreast Cancer | HER2-positive Breast CancerChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Zhejiang Cancer HospitalJiangsu HengRui Medicine Co., Ltd.UnknownMetastatic Breast CancerChina
-
Samsung Bioepis Co., Ltd.CompletedHER2 Positive Early or Locally Advanced Breast CancerCzechia
-
SanofiCompleted
-
Shandong Cancer Hospital and InstituteNot yet recruiting
-
Guangdong Provincial People's HospitalNot yet recruitingNeoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer
-
First Affiliated Hospital of Zhejiang UniversityRecruitingBreast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive TumorChina
-
Shanghai Zhongshan HospitalCompleted
-
Guangdong Provincial People's HospitalRecruitingNeoadjuvant Therapies for HER2+ Breast CancerChina
-
Carilion ClinicSanofiTerminatedAdvanced Endometrial Adenocarcinoma, Stage III A, B, CUnited States
-
SanofiCompletedLung NeoplasmsTurkey
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Pulmonary Hospital, Shanghai, ChinaTerminatedNon Squamous Non Small Cell LungChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting
-
NRG OncologyNational Cancer Institute (NCI)RecruitingMalignant Solid NeoplasmUnited States, Puerto Rico
-
Miguel Martín JiménezUNC Lineberger Comprehensive Cancer Center; Hospital Universitario Ramon y... and other collaboratorsActive, not recruitingBreast Cancer | Breast Cancer Stage II-IIISpain
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Herbert Irving Comprehensive Cancer CenterUnknownOvarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal Cavity CancerUnited States
-
Hope Cancer Institute, Inc.UnknownLung CancerUnited States
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon Small Cell Lung Cancer Metastatic | HER2 Gene Mutation | Non Small Cell Lung Cancer Stage IIIFrance
-
University College London HospitalsCompletedBreast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2) | brca1 Mutation Carrier | brca2 Mutation CarrierAustralia, Israel, United Kingdom, Spain, Sweden, Portugal
-
King Faisal Specialist Hospital & Research CenterCompleted
-
CinnagenCompletedHER2-positive Breast CancerIran, Islamic Republic of
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
PfizerCompleted
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedEsophageal CancerUnited States, Puerto Rico, South Africa
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedCervical CancerUnited States
-
Jeroen Bosch ZiekenhuisUnknownSmall Cell Lung CancerNetherlands
-
Eric Winer, MDMassachusetts General Hospital; Yale University; Dana-Farber Cancer Institute; Beth... and other collaboratorsCompletedBreast CancerUnited States
-
Merrimack PharmaceuticalsCompletedHER-2 Gene AmplificationUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedEsophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Stage IIA Esophageal Cancer AJCC v7 | Stage IIB Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IB Esophageal Cancer AJCC v7United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Peritoneal Cavity CancerUnited States
-
SanofiCompletedBreast NeoplasmsFrance, Brazil, Poland, Germany, Belgium, Tunisia, United Kingdom, Uruguay
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve IncCompletedBreast Cancer Recurrent | Breast Cancer Female | Breast Cancer MetastaticVietnam
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve IncCompletedBreast Cancer Recurrent | Breast Cancer Female | Breast Cancer MetastaticVietnam
-
Samyang Biopharmaceuticals CorporationCompleted